Roche

Genentech
Switzerland
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Danger
High Risk

Summary:

Roche, a Swiss healthcare company, fired a small group of employees for not abiding by the company's vaccine mandate. Roche scored a 100 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, the company increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Roche forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. The company has supported the Equality Act. Roche discriminates against religious organizations in its charitable giving but has not used its PAC for ideological purposes. For these reasons, Roche receives a High Risk rating.

Generate Reports
Clear
Toast